We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $463M
1-Year Est. Return 16%
This Fund
S&P 500
This Quarter Est. Return
-3.41%
1 Year Est. Return
+16%
3 Year Est. Return
+35.45%
5 Year Est. Return
+32.62%
10 Year Est. Return
+255.18%
AUM
$1.17B
AUM Growth
-$132M
Cap. Flow
-$81.6M
Cap. Flow %
-6.97%
Top 10 Hldgs %
17.89%
Holding
224
New
35
Increased
23
Reduced
60
Closed
23

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$19M
2
CAT icon
Caterpillar
CAT
+$15.9M
3
KMB icon
Kimberly-Clark
KMB
+$13.8M
4
PPL
PPL Corp
PPL
+$13.4M
5
CTSH icon
Cognizant
CTSH
+$11.8M

Top Sells

Rank Stock Value
1
ADM icon
Archer Daniels Midland
ADM
+$14.7M
2
BDX icon
Becton Dickinson
BDX
+$14.6M
3
HP icon
Helmerich & Payne
HP
+$14.5M
4
MMM icon
3M
MMM
+$14.4M
5
ELV icon
Elevance Health
ELV
+$11.5M

Sector Composition

Rank Sector Weight
1 Technology 24.41%
2 Healthcare 15.01%
3 Materials 10.39%
4 Industrials 10.22%
5 Energy 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTHR icon
76
United Therapeutics
UTHR
$25.8B
$6.43M 0.55%
50,000
-84,000
-63% -$8.66M
LH icon
77
Labcorp
LH
$25B
$6.4M 0.55%
73,216
K
78
DELISTED
Kellanova
K
$6.34M 0.54%
109,695
+106,500
+3,333% +$6.42M
SAPE
79
DELISTED
SAPIENT CORP
SAPE
$6.34M 0.54%
453,000
DLB icon
80
Dolby
DLB
$5.51B
$6.27M 0.54%
+150,000
New +$6.65M
FDS icon
81
Factset
FDS
$9.36B
$6.08M 0.52%
+50,000
New +$6.18M
MNK
82
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$6.07M 0.52%
+67,275
New +$5.26M
MUSA icon
83
Murphy USA
MUSA
$11.2B
$5.97M 0.51%
112,500
FFIV icon
84
F5
FFIV
$22.9B
$5.94M 0.51%
50,000
IPXL
85
DELISTED
Impax Laboratories, Inc.
IPXL
$5.93M 0.51%
250,000
-60,000
-19% -$1.54M
PLXS icon
86
Plexus
PLXS
$6.72B
$5.91M 0.5%
160,000
-40,000
-20% -$1.62M
ABBV icon
87
AbbVie
ABBV
$443B
$5.78M 0.49%
100,000
-200,000
-67% -$11.1M
SYY icon
88
Sysco
SYY
$40.8B
$5.75M 0.49%
151,500
+50,000
+49% +$1.87M
CA
89
DELISTED
CA, Inc.
CA
$5.73M 0.49%
205,000
-276,000
-57% -$7.88M
BDX icon
90
Becton Dickinson
BDX
$45.6B
$5.69M 0.49%
51,250
-128,125
-71% -$14.6M
EIX icon
91
Edison International
EIX
$28.2B
$5.65M 0.48%
101,000
-50,000
-33% -$2.86M
UI icon
92
Ubiquiti
UI
$33.7B
$5.63M 0.48%
+150,000
New +$6.37M
NFX
93
DELISTED
Newfield Exploration
NFX
$5.56M 0.48%
150,000
SYNA icon
94
Synaptics
SYNA
$4.19B
$5.49M 0.47%
75,000
-100,000
-57% -$8.15M
JBLU icon
95
JetBlue
JBLU
$2.28B
$5.31M 0.45%
500,000
-250,000
-33% -$2.85M
GRMN
96
Garmin
GRMN
$56.7B
$5.2M 0.44%
+100,000
New +$5.54M
CLX icon
97
Clorox
CLX
$11.6B
$5.09M 0.43%
53,000
GOLD
98
DELISTED
Randgold Resources Ltd
GOLD
$5.07M 0.43%
76,110
TECD
99
DELISTED
Tech Data Corp
TECD
$5M 0.43%
+85,000
New +$5.49M
RHI icon
100
Robert Half
RHI
$3.87B
$4.9M 0.42%
100,000

Similar funds

Hussman Strategic Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, Hussman Strategic Advisors held 224 positions worth $1.17B, down 10% from $1.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Hussman Strategic Advisors withdrew a net $81.6M in Q3 2014, closing 23 positions and reducing 60 holdings. Its most notable exit was Helmerich & Payne, an estimated $14.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Materials.

Against the trend, Hussman Strategic Advisors opened a new position in Caterpillar worth $14.9M.

  • Hussman Strategic Advisors's largest Q3 2014 buy was Caterpillar: 150,000 shares worth $14.9M.
  • Hussman Strategic Advisors added most to Eli Lilly in Q3 2014, an estimated $19M increase.
  • Hussman Strategic Advisors's biggest Q3 2014 reduction was Archer Daniels Midland, cutting an estimated $14.7M.
  • Hussman Strategic Advisors fully exited Helmerich & Payne in Q3 2014, selling an estimated $14.5M.
  • Hussman Strategic Advisors's ten largest holdings make up 18% of its $1.17B portfolio in Q3 2014.
  • Hussman Strategic Advisors opened 35 new positions and closed 23 in Q3 2014.
  • Hussman Strategic Advisors's portfolio value fell 10% quarter-over-quarter to $1.17B.

Based on Hussman Strategic Advisors's 13F filing for Q3 2014, filed 31 Oct 2014.